Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.24.1.1.u2
Equity (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended
Sep. 29, 2023
USD ($)
$ / shares
shares
Feb. 05, 2023
USD ($)
$ / shares
shares
Oct. 05, 2022
Aug. 08, 2022
USD ($)
Mar. 31, 2024
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
Dec. 31, 2023
shares
Oct. 05, 2023
shares
Apr. 24, 2023
$ / shares
Jul. 22, 2022
$ / shares
Jul. 20, 2022
$ / shares
Jul. 11, 2022
shares
Subsidiary or Equity Method Investee [Line Items]                        
Preferred stock, shares authorized (in shares)         10,000,000   10,000,000          
Preferred stock dividends accumulated but not declared and unpaid | $         $ 1,400              
7.5% Series B Cumulative Perpetual Redeemable Preferred Stock                        
Subsidiary or Equity Method Investee [Line Items]                        
Dividend rate (in percentage)         7.50%              
Dividend rate increase after first reset date         0.015              
Yorkville                        
Subsidiary or Equity Method Investee [Line Items]                        
Purchase share price (in dollars per share) | $ / shares                   $ 11.50 $ 23.00  
Yorkville | Convertible Debt                        
Subsidiary or Equity Method Investee [Line Items]                        
Purchase share price (in dollars per share) | $ / shares                 $ 2.30      
Yorkville | 7.5% Series B Cumulative Perpetual Redeemable Preferred Stock | Fourth Convertible Debentures and Warrants | Convertible Debt                        
Subsidiary or Equity Method Investee [Line Items]                        
Issuance of shares under legal settlement (in shares)         0              
Minimum                        
Subsidiary or Equity Method Investee [Line Items]                        
Corresponding increase in the total number of authorized share (in shares)               1,000,000,000        
Minimum | Common Stock                        
Subsidiary or Equity Method Investee [Line Items]                        
Corresponding increase in the total number of authorized share (in shares)               1,000,000,000        
Maximum                        
Subsidiary or Equity Method Investee [Line Items]                        
Corresponding increase in the total number of authorized share (in shares)               2,000,000,000        
Maximum | Common Stock                        
Subsidiary or Equity Method Investee [Line Items]                        
Corresponding increase in the total number of authorized share (in shares)               2,000,000,000        
Securities Purchase Agreement                        
Subsidiary or Equity Method Investee [Line Items]                        
Warrants outstanding (in shares)   100,000                    
Warrant Agreement                        
Subsidiary or Equity Method Investee [Line Items]                        
Warrants outstanding (in shares)   2,200,000                   2,700,000
Warrant Agreement | RDO SPA Warrants                        
Subsidiary or Equity Method Investee [Line Items]                        
Warrants outstanding (in shares)   2,200,000                    
Purchase share price (in dollars per share) | $ / shares         $ 3.57              
Side Letter to the Wainwright Sales Agreement                        
Subsidiary or Equity Method Investee [Line Items]                        
Manager commissions, percent of gross proceeds     3.00%                  
Sale of stock, percentage of additional fee     1.50%                  
Registered Direct Offering & Placement Agency Agreement | Warrant Agreement                        
Subsidiary or Equity Method Investee [Line Items]                        
Corresponding increase in the total number of authorized share (in shares)   2,200,000                    
Purchase share price (in dollars per share) | $ / shares   $ 24.15                    
Registered Direct Offering & Placement Agency Agreement | Warrant Agreement | RDO SPA Warrants                        
Subsidiary or Equity Method Investee [Line Items]                        
Proceeds from issuance of warrants | $   $ 49,400                    
Securities Purchase Agreement                        
Subsidiary or Equity Method Investee [Line Items]                        
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE | $           $ 1,600            
Series B Preferred Stock Purchase Agreement | 7.5% Series B Cumulative Perpetual Redeemable Preferred Stock                        
Subsidiary or Equity Method Investee [Line Items]                        
Purchase share price (in dollars per share) | $ / shares         $ 3.57              
Preferred stock, shares authorized (in shares) 45,000                      
Dividend rate (in percentage) 7.50%                      
Preferred stock, par value per share (in dollars per share) | $ / shares $ 0.0001                      
Preferred stock, stated value per share (in dollars per share) | $ / shares $ 1,000                      
Series B Preferred Stock Purchase Agreement | Warrant Agreement                        
Subsidiary or Equity Method Investee [Line Items]                        
Proceeds from issuance of warrants | $ $ 45,000                      
Series B Preferred Stock Purchase Agreement | Warrant Agreement | 7.5% Series B Cumulative Perpetual Redeemable Preferred Stock                        
Subsidiary or Equity Method Investee [Line Items]                        
Warrants outstanding (in shares) 1,000,000                      
Preferred stock, convertible, conversion price (in dollars per share) | $ / shares $ 12.88                      
Preferred stock, convertible, conversion ratio 1.200                      
Preferred stock, liquidation preference (in percentage) 103.00%                      
Preferred stock, liquidation preference, value | $         $ 46,300              
Common Stock | At The Market Offering Agreement                        
Subsidiary or Equity Method Investee [Line Items]                        
Sale of stock consideration | $       $ 200,000                
Additional Paid-in Capital | Securities Purchase Agreement                        
Subsidiary or Equity Method Investee [Line Items]                        
Issuance of shares under the PPA, SPA , ATM, SEPA and PIPE | $         $ 1,600 $ 1,600 [1]            
[1] Periods presented have been adjusted to reflect the 1-for-23 reverse stock split on March 8, 2024. See Note 1- Organization and Basis of Presentation - Reverse Stock Split, for additional information.